EGFR and cancer: Consistent with this finding, RGD binding integrin has previously been linked to the regulation of EGFR‐mutated cancer cell sensitivity to first‐generation TKIs.[22] However, the mechanisms underlying its functional role in regulating cancer cell sensitivity to TKIs have remained unclear until now.